| | | | | |
CTKB Cytek Biosciences, Inc. Common Stock | €3,7992 | -7,90% | €532,84M | €700,19K | |
FDMT 4D Molecular Therapeutics, Inc. Common Stock | €13,1813 | -2,91% | €532,15M | €1,11M | |
EIKN Eikon Therapeutics, Inc. Common Stock | €9,5880 | -1,84% | €531,61M | €301,54K | |
| €16,3802 | +0,74% | €531,26M | €120,31K | |
| €50,8342 | -0,28% | €530,53M | €40,62K | |
EMD Western Asset Emerging Markets Debt Fund, Inc | €9,0048 | -0,94% | €530,43M | €114,66K | |
CBNK Capital Bancorp, Inc. | €31,3367 | +0,03% | €529,20M | €29,13K | |
NRDS NerdWallet, Inc. Class A Common Stock | €8,6961 | +2,63% | €529,01M | €505,40K | |
| €63,7154 | +3,61% | €528,77M | €125,21K | |
TRAX First Tracks Biotherapeutics, Inc. Ordinary Shares | €37,1084 | +0,37% | €527,85M | €519,14K | |
CGNT Cognyte Software Ltd. Ordinary Shares | €7,3239 | -0,70% | €526,54M | €508,45K | |
BWB Bridgewater Bancshares, Inc. Common Stock | €18,6013 | +0,28% | €526,32M | €109,10K | |
VINP Vinci Compass Investments Ltd. Class A Common Shares | €8,2673 | +1,26% | €525,86M | €38,02K | |
ELMT The Elmet Group Co. Common Stock | €15,1752 | -11,00% | €525,65M | €476,42K | |
| €6,1919 | +3,44% | €524,67M | €722,62K | |
